TSHA
TSHA
NASDAQ · Biotechnology

Taysha Gene Therapies Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$6.71
+0.04 (+0.60%)
As of May 9, 1:36 AM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 19 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +807.0% upside
Low Target $45.99
Average Target $60.86
High Target $68.15
Current Price $6.71
Current
$6.71
Target
$60.86
$45.99 $60.86 avg $68.15
Scenario Analysis
Bear Case
$45.99
585.4%
Low target
Base Case
$60.86
+807.0%
Avg target
Bull Case
$68.15
+915.6%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$7.30
-8.1% from high
52-Week Low
$1.85
+263.7% from low
Target vs 52W High
$60.86
+733.7% vs high
Next Earnings Report
May 20, 2026
9d
until earnings
EPS Est: $-0.10
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%